Oral steroids for hearing loss associated with otitis media with effusion in children aged 2–8 years: the OSTRICH RCT | Zendy

Nick Francis | Zendy; Cherry-Ann Waldron | Zendy; Rebecca CanningsJohn | Zendy; Emma ThomasJones | Zendy; Thomas G Winfield | Zendy; Victoria Shepherd | Zendy; Debbie Harris | Zendy; Kerenza Hood | Zendy; Deborah Fitzsimmons | Zendy; Amanda Roberts | Zendy; Colin Powell | Zendy; Micaela Gal | Zendy; Sarah Jones | Zendy; Christopher Butler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Oral steroids for hearing loss associated with otitis media with effusion in children aged 2–8 years: the OSTRICH RCT

Author(s) -

Nick Francis,

Cherry-Ann Waldron,

Rebecca CanningsJohn,

Emma ThomasJones,

Thomas G Winfield,

Victoria Shepherd,

Debbie Harris,

Kerenza Hood,

Deborah Fitzsimmons,

Amanda Roberts,

Colin Powell,

Micaela Gal,

Sarah Jones,

Christopher Butler

Publication year - 2018

Publication title -

health technology assessment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.426

H-Index - 126

eISSN - 2046-4924

pISSN - 1366-5278

DOI - 10.3310/hta22610

Subject(s) - medicine , randomized controlled trial , otitis , hearing loss , effusion , tympanometry , pediatrics , audiology , surgery , audiometry

Children with hearing loss associated with otitis media with effusion (OME) are commonly managed through surgical intervention, hearing aids or watchful waiting. A safe, inexpensive, effective medical treatment would enhance treatment options. Small, poorly conducted trials have found a short-term benefit from oral steroids.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research